Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Chiesi
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
Juxtapid
(lomitapide) / Novelion, Chiesi
tanimilast
(CHF6001) / Chiesi
Elfabrio
(pegunigalsidase alfa) / Protalix, Chiesi
timapiprant
(OC000459) / Chiesi
Filsuvez
(AP101) / Chiesi
Procysbi
(cysteamine bitartrate delayed release) / Amgen
Quinsair
(levofloxacin inhalational) / Chiesi, Amgen
Glybera
(alipogene tiparvovec) / uniQure, Chiesi, Xenon
Ventmax SR
(salbutamol sulphate) / Chiesi
Mycapssa
(octreotide) / Chiesi
Tanatril
(imidapril) / Chiesi, GL PharmTech, Mitsubishi Tanabe
Peyona
(caffeine citrate) / Chiesi
Budiair
(budesonide hydrofluoroalkane) / Chiesi
CUSA-081
(reteplase) / Chiesi
Clenil Modulite
(beclometasone pressurised metered-dose inhaler) / Chiesi, GSK
Revcovi
(elapegademase-lvlr) / Teijin, Chiesi
